ANL 29.80 Decreased By ▼ -1.55 (-4.94%)
ASC 20.40 Decreased By ▼ -0.50 (-2.39%)
ASL 23.60 Decreased By ▼ -0.30 (-1.26%)
BOP 8.26 Decreased By ▼ -0.15 (-1.78%)
BYCO 9.88 Decreased By ▼ -0.16 (-1.59%)
FCCL 21.85 Decreased By ▼ -0.35 (-1.58%)
FFBL 26.91 Decreased By ▼ -0.53 (-1.93%)
FFL 20.00 Decreased By ▼ -0.79 (-3.8%)
FNEL 8.74 Decreased By ▼ -0.11 (-1.24%)
GGGL 26.40 Decreased By ▼ -1.05 (-3.83%)
GGL 46.04 Decreased By ▼ -1.06 (-2.25%)
HUMNL 7.05 Decreased By ▼ -0.35 (-4.73%)
JSCL 21.62 Decreased By ▼ -0.88 (-3.91%)
KAPCO 38.70 Decreased By ▼ -1.10 (-2.76%)
KEL 3.90 Decreased By ▼ -0.02 (-0.51%)
MDTL 3.56 Decreased By ▼ -0.17 (-4.56%)
MLCF 43.50 Decreased By ▼ -0.77 (-1.74%)
NETSOL 158.50 Decreased By ▼ -7.45 (-4.49%)
PACE 7.45 Decreased By ▼ -0.22 (-2.87%)
PAEL 33.65 Decreased By ▼ -0.36 (-1.06%)
PIBTL 11.00 Decreased By ▼ -0.25 (-2.22%)
POWER 9.20 No Change ▼ 0.00 (0%)
PRL 23.00 Decreased By ▼ -0.80 (-3.36%)
PTC 11.60 Decreased By ▼ -0.13 (-1.11%)
SILK 1.83 Increased By ▲ 0.01 (0.55%)
SNGP 49.80 Increased By ▲ 0.20 (0.4%)
TELE 14.80 Decreased By ▼ -0.26 (-1.73%)
TRG 159.45 Decreased By ▼ -6.75 (-4.06%)
UNITY 40.45 Decreased By ▼ -2.52 (-5.86%)
WTL 3.59 Decreased By ▼ -0.15 (-4.01%)
BR100 5,096 Decreased By ▼ -70.59 (-1.37%)
BR30 25,755 Decreased By ▼ -734.03 (-2.77%)
KSE100 47,318 Decreased By ▼ -368.96 (-0.77%)
KSE30 18,974 Decreased By ▼ -155.31 (-0.81%)

Coronavirus
VERY HIGH Source: covid.gov.pk
Pakistan Deaths
23,133
4424hr
Pakistan Cases
1,015,827
4,11924hr
7.88% positivity
Sindh
371,762
Punjab
354,312
Balochistan
29,861
Islamabad
86,226
KPK
142,400

AstraZeneca vaccine

Sudan to start vaccine rollout next week after getting COVAX doses

Sudan to start vaccine rollout next week after getting COVAX doses

  • Sudan says it expects to receive the remainder of a total 3.4 million doses through COVAX, a vaccine-sharing programme co-led by the World Health Organization, in the second quarter of this year.
  • "This is an essential part of our battle against coronavirus," Health Minister Omer Elnageib said.
Published 04 Mar, 2021 07:03pm
Sweden recommends AstraZeneca COVID-19 vaccine for over 65s
World

Sweden recommends AstraZeneca COVID-19 vaccine for over 65s

  • There are new studies, from England and Scotland for instance, showing that Astrazeneca's vaccine offers a very good protection in these age groups.
  • Sweden, which has avoided imposing throughout the pandemic, registered 4,838 new coronavirus cases on Thursday, health agency statistics showed.
Updated 04 Mar, 2021 09:54pm
Germany approves AstraZeneca for over-65s
World

Germany approves AstraZeneca for over-65s

  • It added that the Permanent Vaccination authority recommended extending to the maximum 12 weeks the period between receiving the first and second doses of the vaccine.
  • "This is good news for older people who are waiting for a vaccine. They can now be vaccinated more quickly," the ministry said.
Published 04 Mar, 2021 06:01pm
Malaysia approves Sinovac, AstraZeneca COVID-19 vaccines for use
World

Malaysia approves Sinovac, AstraZeneca COVID-19 vaccines for use

  • Malaysia began its vaccination drive on Feb. 24 using a shot developed by US drugmaker Pfizer and German partner BioNTech, as it tries to rein in a spike in infections and help revive an economy that recorded its worst slump in more than two decades last year.
  • Sinovac signed a deal with Malaysia's Pharmaniaga, which will carry out a fill-and-finish process for the vaccine's distribution in Malaysia, before later manufacturing it locally.
Published 02 Mar, 2021 07:17pm
Take 'fantastic' AstraZeneca vaccine, top officials tell Germans
World

Take 'fantastic' AstraZeneca vaccine, top officials tell Germans

  • German officials have expressed growing disquiet over the quantities of the AstraZeneca vaccine being left untaken by nervous Germans.
  • "We strongly recommend it: this vaccine is safe and effective, it protects," Health Minister Jens Spahn told a news conference.
Published 26 Feb, 2021 07:04pm
AstraZeneca/Oxford vaccine more effective with longer dose gap: study
Business & Finance

AstraZeneca/Oxford vaccine more effective with longer dose gap: study

  • The study confirmed the Anglo-Swedish drugmaker's findings from earlier this month that showed the vaccine had 76% efficacy against symptomatic coronavirus infection for three months after the first dose.
  • Efficacy was found to be at 81% with the longer interval of 12 weeks between the first and second dose, compared with 55% efficacy up to the six-week gap.
Published 19 Feb, 2021 09:17pm
Ghana expects first delivery of AstraZeneca vaccine shots
World

Ghana expects first delivery of AstraZeneca vaccine shots

  • The country will spend around $3 for every two shots of vaccine and inoculate around 20 million people against the virus, according to the plan.
  • On the estimated cost, we are looking at...for every person getting two shots, that would cost nearly $3 per person fully vaccinated for the two doses.
Published 19 Feb, 2021 07:17pm